Marker Therapeutics Azioni (NASDAQ: MRKR)

Ultime notizie per Marker Therapeutics (NASDAQ:MRKR) Azioni

Marker Therapeutics

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

Marker Therapeutics Inc

News

General

During Conference Call, EA Exec Reportedly Says Co Is Not Looking To Make Any Changes To Game Pricing At This Stage

Primerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRI#NYSE">PRI</a>) has outperformed the market over the past 15 years by 5.52% on an annualized basis producing an average annual return of 17.72%. Currently, Primerica has a market capitalization of $8.77 billion. 
Buying $1000 In PRI: If an investor had bought $1000 of PRI stock 15 years ago, it would be worth $11,813.72 today based on a price of $266.99 for PRI at the time of writing.
<h3>Primerica's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1753824618_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $1000 Invested In Primerica 15 Years Ago Would Be Worth Today

During Conference Call, Visa Exec Reportedly Says We See No Meaningful Impact From Tariffs For Cross Border Payments

Restaurant company Cheesecake Factory Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAKE#NASDAQ">CAKE</a>) reported better-than-expected financial results for the second fiscal quarter <a href="https://www.benzinga.com/earnings">after market close Tuesday.</a>
How is CAKE stock moving? <a href="https://www.benzinga.com/quote/CAKE" target="_blank" rel="noreferrer noopener">See real-time price here.</a>
What Happened: Cheesecake Factory reported second-quarter revenue of $955.8 million, up 5.7% from last year's second quarter total of $904 million. The revenue beat a Street consensus estimate of $946.79 million according to data <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0729">from Benzinga Pro.</a>
The company reported adjusted earnings per share of $1.16 in the quarter, beating a Street consensus estimate of $1.05.
Comparable restaurant sales for The Cheesecake Factory were up 1.2% year-over-year in the second quarter.
"We delivered another quarter of strong results, with record-high revenue, continued margin expansion, and profitability that exceeded our guidance," Cheesecake Factory CEO David Overton said.
Overton said the restaurants saw strong comparable sales and healthy consumer demand during the quarter.
The company opened eight new restaurants across different concepts in the quarter. The company has opened 16 restaurants during the first half of 2025. After the end of the quarter, the company opened a Cheesecake Factory restaurant in Mexico under a license agreement.
"We're pleased with the progress we've made on new unit growth so far this year."
The company said it could open as many as 25 new restaurants in fiscal 2025, including four The Cheesecake Factory restaurants, six North Italia locations, six Flower Child locations and nine FRC restaurants.
CAKE Price Action: Cheesecake Factory Inc shares are up 5.87% to $66.89 in after-hours trading Tuesday versus a 52-week trading range of $33.50 to $69.70.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/05/45148086/cheesecake-factory-earnings-leave-sweet-taste-but-analyst-sees-tariff-trouble-brewing">Cheesecake Factory Earnings Leave Sweet Taste, But Analyst Sees Tariff Trouble Brewing</a></li>
</ul>

Photo: Shutterstock

Earnings

Restaurants

Movers

CAKE

Cheesecake Factory Shares Snapped Up Tuesday, Here's Why

Toromont Industries (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TIH#TSX">TIH</a>) reported quarterly earnings of $1.52 per share which beat the analyst consensus estimate of $1.49 by 2.01 percent. This is a 7.88 percent decrease over earnings of $1.65 per share from the same period last year. The company reported quarterly sales of $1.377 billion which beat the analyst consensus estimate of $1.352 billion by 1.85 percent. This is a 1.25 percent increase over sales of $1.360 billion the same period last year.

Earnings Beats

TSX:TIH

Toromont Industries Q2 EPS $1.52 Beats $1.49 Estimate, Sales $1.377B Beat $1.352B Estimate

Excelerate Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EE#NYSE">EE</a>) (the "Company" or "Excelerate") today raised its full year 2025 Adjusted EBITDA guidance range and filed a Form 8-K/A with pro forma financial results related to the acquisition of New Fortress Energy Inc.'s ("Seller") business in Jamaica.
KEY HIGHLIGHTS
<ul>
<li>Excelerate closed its acquisition of the integrated LNG and power platform in Jamaica in May 2025 (the "Jamaica Acquisition")</li>
<li>Following the closing of the Jamaica Acquisition, the Company now expects full year 2025 Adjusted EBITDA guidance to range between $420 million and $440 million</li>
<li>The Company has filed a Form 8-K/A with pro forma financial information that incorporates the Seller's historical results from its Jamaica operations</li>
<li>The pro forma financial results include certain cost allocations to the Jamaica business based on assumptions and methodologies specific to the Seller</li>
<li>After removing these Seller-specific cost allocations, pro forma Adjusted EBITDA for both the three-month period ended March 31, 2025 and the full year ended 2024 are aligned with Excelerate management expectations
<ul>
<li>A slide presentation with a reconciliation of the pro forma financial results and updated full year 2025 Adjusted EBITDA guidance range is available on the Company's IR website</li>
</ul>
</li>
</ul>

Guidance

Excelerate Energy Says Following The Closing Of The Jamaica Acquisition, The Company Now Expects FY25 Adjusted EBITDA Guidance To Range Between $420M-$440M

Biotech

COYA

Coya Therapeutics Says FDA Unable To Meet Review Goal Date For Coya's Ind For Phase 2 Als Study; FDA Decision On Coya's Ind Expected By August 29, 2025

Allied Properties REIT (TSX:<a class="ticker" href="https://www.benzinga.com/stock/AP#TSX">AP</a>) reported quarterly earnings of $0.49 per share. This is a 6.6 percent decrease over earnings of $0.53 per share from the same period last year. The company reported $145.045 million in sales this quarter. This is a 1.16 percent decrease over sales of $146.750 million the same period last year.

TSX:AP

Allied Properties REIT Q2 FFO $0.49 Down From $0.53 YoY, Sales $145.045M Down From $146.750M YoY

Boardwalk REIT (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BEI#TSX">BEI</a>) raises FY2025 FFO guidance from $3.72-$3.97 to $3.85-$4.00..

TSX:BEI

Boardwalk REIT Raises FY2025 FFO Guidance from $3.72-$3.97 to $3.85-$4.00

SoFi Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) ("SoFi" or the "Company") today announced an underwritten public offering of $1.5 billion of shares of its common stock. In connection with the offering, SoFi expects to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the offering. All of the shares of common stock in the offering will be sold by SoFi.&nbsp; SoFi intends to use the net proceeds from the offering for general corporate purposes, including working capital and other business opportunities.
Goldman Sachs &amp; Co. LLC ("Goldman") will act as the underwriter in the offering. An automatic shelf registration statement on Form S-3 (Registration No. 333-289046) (including a base prospectus) became effective upon filing with the Securities and Exchange Commission on July 29, 2025. The offering will be made only by means of a preliminary prospectus supplement and a final prospectus supplement (together, the "prospectus supplement") and an accompanying base prospectus. Before investing, prospective investors should read the preliminary prospectus supplement, the accompanying base prospectus and the documents incorporated by reference therein for more complete information about the Company and the offering. You may get these documents, including the prospectus supplement, for free by visiting EDGAR on the SEC website at <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov&amp;esheet=54299065&amp;newsitemid=20250729367428&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=1&amp;md5=2d1b58bdb5e08e7ab3cc634f4fe1526c">www.sec.gov</a>. Copies of the prospectus supplement, when available, and the accompanying prospectus relating to this offering may be obtained by contacting: Goldman Sachs &amp; Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, Telephone: (866) 471-2526 or via email: <a href="mailto:prospectus-ny@ny.email.gs.com">prospectus-ny@ny.email.gs.com</a>.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

SOFI

SoFi Technologies Reveals An Underwritten Public Offering Of $1.5B Of Shares Of Its Common Stock

Intact Financial (TSX:<a class="ticker" href="https://www.benzinga.com/stock/IFC#TSX">IFC</a>) reported quarterly earnings of $5.23 per share which beat the analyst consensus estimate of $3.98 by 31.41 percent. This is a 13.45 percent increase over earnings of $4.61 per share from the same period last year. The company reported quarterly sales of $7.031 billion which beat the analyst consensus estimate of $5.804 billion by 21.15 percent. This is a 5.65 percent increase over sales of $6.655 billion the same period last year.

TSX:IFC

Intact Financial Q2 Adj. EPS $5.23 Beats $3.98 Estimate, Sales $7.031B Beat $5.804B Estimate

NMIH

CORRECTION: NMI Holdings Q2 Adj. EPS $1.22, Inline, Sales $173.779M Beat $147.955M Estimate

Seagate Technology Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>) reported fourth-quarter financial results for fiscal 2025 after the market close on Tuesday. Here&#8217;s a rundown <a href="https://www.benzinga.com/pressreleases/25/07/b46704764/seagate-technology-reports-fiscal-fourth-quarter-and-fiscal-year-2025-financial-results">of the report</a>.
<ul class="wp-block-list">
<li>Q4 Revenue: $2.44 billion, versus <a href="http://benzinga.com/quote/STX/earnings">estimates</a> of $2.42 billion</li>
</ul>
<ul class="wp-block-list">
<li>Q4 Adjusted EPS: $2.59, versus estimates of $2.43</li>
</ul>
STX shares are currently under heavy selling pressure. <a href="https://www.benzinga.com/quote/STX" target="_blank" rel="noreferrer noopener">See the chart here.</a>
Seagate said it generated $508 million in cash flow from operations and $425 million in free cash flow in the quarter. The company had $891 million in total cash and cash equivalents at the end of the quarter. 
&#8220;Seagate&#8217;s strong FQ4 performance underscores our commitment to profitable growth, marked by a&nbsp;30%&nbsp;year-over-year revenue increase, record gross margin, and non-GAAP EPS expanding to the top of our&nbsp;guidance&nbsp;range,&#8221; said Dave Mosley, CEO of Seagate.
&#8220;These achievements reflect the structural enhancements we&#8217;ve implemented in our business and ongoing demand strength from cloud customers for our high-capacity drives.&#8221;
Seagate&#8217;s board declared a quarterly cash dividend of 72 cents per share, payable on Oct. 9 to shareholders of record as of Sept. 30. The company paid $153 million of cash dividends in the second quarter.
Guidance: Seagate expects fiscal first-quarter revenue to be in the range of $2.35 billion to $2.65 billion versus estimates of $2.5 billion, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. The company sees first-quarter adjusted earnings of $2.10 to $2.50 per share versus estimates of $2.28 per share.
STX Price Action: <a href="http://benzinga.com/quote/STX">Seagate shares</a> were down 7.64% in after-hours, trading at $141.02 at the time of publication on Tuesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/earnings/25/07/46706017/starbucks-q3-earnings-revenue-beat-eps-miss-turnaround-efforts-ahead-of-schedule">Starbucks Q3 Earnings: Revenue Beat, EPS Miss, Turnaround Efforts &#8216;Ahead Of Schedule&#8217;</a></li>
<li><a href="https://www.benzinga.com/markets/earnings/25/07/46706276/electronic-arts-q1-earnings-highlights-revenue-beat-ceo-says-most-exciting-launch-slate-coming">Electronic Arts Q1 Earnings Highlights: Revenue Beat, CEO Says &#8216;Most Exciting Launch Slate&#8217; Coming</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/Andrei+Stanescu">Sundry Photography</a>/Shutterstock.com

Tech

Seagate Technology Beats Q4 Estimates On Continued Demand Strength From Cloud Customers

Fair Isaac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FICO#NYSE">FICO</a>) has outperformed the market over the past 5 years by 13.91% on an annualized basis producing an average annual return of 27.99%. Currently, Fair Isaac has a market capitalization of $36.64 billion. 
Buying $100 In FICO: If an investor had bought $100 of FICO stock 5 years ago, it would be worth $342.69 today based on a price of $1505.06 for FICO at the time of writing.
<h3>Fair Isaac's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1753823714_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FICO

Here's How Much $100 Invested In Fair Isaac 5 Years Ago Would Be Worth Today

Republic Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSG#NYSE">RSG</a>) lowers FY2025 GAAP EPS guidance from $6.79-$6.87 to $6.72-$6.74 vs $6.86 analyst estimate. Affirms FY2025 sales outlook from $16.675 billion-$16.750 billion to $16.675 billion-$16.750 billion vs $16.872 billion estimate.

Republic Services Lowers FY2025 GAAP EPS Guidance from $6.79-$6.87 to $6.72-$6.74 vs $6.86 Est; Affirms FY2025 Sales Guidance of $16.675B-$16.750B vs $16.872B Est

ILPT

CORRECTION: Industrial Logistics Q2 FFO $0.21 Beats $0.20 Estimate, Sales $112.097M Beat $111.675M Estimate

Jones Trading analyst Jason Weaver maintains Seven Hills Realty Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEVN#NASDAQ">SEVN</a>) with a Buy and lowers the price target from $15 to $12.5.

Price Target

Analyst Ratings

SEVN

Jones Trading Maintains Buy on Seven Hills Realty Trust, Lowers Price Target to $12.5

Tetra Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTI#NYSE">TTI</a>) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $0.07 by 30.43 percent. This is a 28.57 percent increase over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $173.87 million which beat the analyst consensus estimate of $172.46 million by 0.82 percent. This is a 1.13 percent increase over sales of $171.94 million the same period last year.

Tetra Technologies Q2 Adj. EPS $0.09 Beats $0.07 Estimate, Sales $173.87M Beat $172.46M Estimate

EcoSynthetix (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ECO#TSX">ECO</a>) reported quarterly sales of $5.005 million which missed the analyst consensus estimate of $51.880 million by 90.35 percent. This is a 57.19 percent increase over sales of $3.184 million the same period last year.

Earnings Misses

TSX:ECO

EcoSynthetix Q2 Sales $5.005M Miss $51.880M Estimate

FNWD

Finward Bancorp Q3 EPS $0.50 Beats $0.24 Estimate, Sales $16.628M Miss $16.850M Estimate

Health Care

Press Releases

Marker Therapeutics to Present at the 2024 Ladenburg Thalmann & Co. Virtual Oncology Innovators and Investors Symposium

Financing

Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer

Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma

Marker Therapeutics Announces $16.1 Million Private Placement

Marker Therapeutics to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference

Marker Therapeutics Reports Year-End 2024 Corporate and Financial Results

Marker Therapeutics to Present at Canaccord Genuity's Horizons in Oncology Conference

Marker Therapeutics to Spotlight Multi-Antigen Recognizing (MAR)-T Cells in High-Profile Panel on CAR-T Cell Therapies

Marker Therapeutics Reports that Lymphodepletion Improves the Expansion and Persistence of Multi-Antigen Recognizing T Cells in Patients with Lymphoma

Contracts

Marker Therapeutics and Cellipont Bioservices Announce Collaboration to Advance cGMP Manufacturing of MT-601, a Multi-Antigen Recognizing T Cell Therapy for Patients with Lymphoma

Comments

Marker Therapeutics

Notizie

Ultime notizie per Marker Therapeutics (NASDAQ:MRKR) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO